ICON Public Limited Company
ICLR
Classement en actions
#1596
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Prix de l'action
$176.12
Capitalisation boursière
$13.59B
Changement (1 jour)
4.75%
Changement (1 an)
-6.54%
Pays
IE
Échange ICON Public Limited Company (ICLR)
Catégorie
Healthcare
Ratio P/B pour ICON Public Limited Company (ICLR)
Ratio P/B au October 2026 TTM : 1.38
Selon les derniers rapports financiers et le cours de l'action de ICON Public Limited Company, le ratio cours/valeur comptable actuel (TTM) est 1.38. À la fin de 2023, le ratio P/B était de 2.52.
Historique du ratio P/B pour ICON Public Limited Company de 2001 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 1.38 | -23.92% |
| 2024 | 1.82 | -27.78% |
| 2023 | 2.52 | 34.95% |
| 2022 | 1.86 | -27.67% |
| 2021 | 2.58 | -53.75% |
| 2020 | 5.57 | -2.83% |
| 2019 | 5.73 | 11.03% |
| 2018 | 5.16 | -0.76% |
| 2017 | 5.20 | 18.37% |
| 2016 | 4.40 | -26.41% |
| 2015 | 5.97 | 81.00% |
| 2014 | 3.30 | 22.07% |
| 2013 | 2.70 | 22.54% |
| 2012 | 2.21 | 45.55% |
| 2011 | 1.52 | -22.35% |
| 2010 | 1.95 | -12.33% |
| 2009 | 2.23 | -11.40% |
| 2008 | 2.51 | 9.93% |
| 2007 | 2.29 | 29.66% |
| 2006 | 1.76 | 47.63% |
| 2005 | 1.19 | 102.27% |
| 2004 | 0.59 | -13.61% |
| 2003 | 0.68 | -14.89% |
| 2002 | 0.80 | -14.44% |
| 2001 | 0.94 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 4.7411 | 242.42% |
US
|
|
| 3.0143 | 117.70% |
US
|
|
| 31.051 | 2,142.60% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 381.30% |
US
|
